HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Bed Bath & Beyond ‘Spyware’ Violates Pennsylvania Wiretap Act – Class Action Complaint

Executive Summary

Visitors to BB&B’s website were not informed and did not consent to its session replay “spyware,” which tracks how consumers interact with the site, “their mouse movements and clicks, keystrokes, search terms, information inputted into the website, and pages and content viewed,” the plaintiff says.

You may also be interested in...



L’Oreal Settles Lawsuit Over Website Accessibility To Blind And Visually Impaired

Revlon settled similar litigation previously, while Bumble & Bumble was hit with a putative class action on 10 November in New York federal court alleging the blind and visually impaired are being denied equal access to its website due to design shortcomings.

CTPA Takes Stand Against ‘Free From’ Claims, Urges Focus On Cosmetics’ ‘Positive Attributes’

In a position paper published on 6 October, the UK cosmetics trade group says “free from” claims can sow confusion among consumers, damage trust in brands and the industry, and lead to safe and effective ingredients no longer being used. In many instances, “free from” claims also may violate UK and EU law, according to CTPA.

L’Oreal USA Faces First In Potential Wave Of Lawsuits Over Hair Straightener-Uterine Cancer Link

In her complaint against L’Oreal and other marketers of hair-smoothing products, plaintiff Jenny Mitchell, who was diagnosed with uterine cancer in August 2018, cites an NIH study published in October as “the first epidemiologic evidence of association between use of straightening products and uterine cancer.” She claims the defendants engaged in negligent or fraudulent practices in their marketing and sale of hair-straightening products that they knew posed dangers to users.

Topics

Latest News
See All
UsernamePublicRestriction

Register

RS153132

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel